These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 24759129)

  • 21. The interaction between GABA and dopamine: implications for schizophrenia.
    Garbutt JC; van Kammen DP
    Schizophr Bull; 1983; 9(3):336-53. PubMed ID: 6137869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABA receptors in brain development, function, and injury.
    Wu C; Sun D
    Metab Brain Dis; 2015 Apr; 30(2):367-79. PubMed ID: 24820774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia.
    Balan S; Yamada K; Iwayama Y; Hashimoto T; Toyota T; Shimamoto C; Maekawa M; Takagai S; Wakuda T; Kameno Y; Kurita D; Yamada K; Kikuchi M; Hashimoto T; Kanahara N; Yoshikawa T
    Schizophr Res; 2017 Jul; 185():33-40. PubMed ID: 28073605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptic dysfunction in schizophrenia.
    Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L
    Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression.
    Ohnuma T; Augood SJ; Arai H; McKenna PJ; Emson PC
    Neuroscience; 1999; 93(2):441-8. PubMed ID: 10465426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schizophrenia: some current neurochemical approaches.
    Rodnight R
    J Neurochem; 1983 Jul; 41(1):12-21. PubMed ID: 6345723
    [No Abstract]   [Full Text] [Related]  

  • 27. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?
    Benes FM
    Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640
    [No Abstract]   [Full Text] [Related]  

  • 28. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia.
    Gonzalez-Burgos G; Fish KN; Lewis DA
    Neural Plast; 2011; 2011():723184. PubMed ID: 21904685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maturation of the GABAergic transmission in normal and pathologic motoneurons.
    Allain AE; Le Corronc H; Delpy A; Cazenave W; Meyrand P; Legendre P; Branchereau P
    Neural Plast; 2011; 2011():905624. PubMed ID: 21785735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation.
    Auteri M; Zizzo MG; Serio R
    Pharmacol Res; 2015 Mar; 93():11-21. PubMed ID: 25526825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurodevelopmental hypothesis of schizophrenia: a central sensory disturbance.
    Lafargue T; Brasic J
    Med Hypotheses; 2000 Oct; 55(4):314-8. PubMed ID: 11000059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.
    Squires RF; Saederup E
    Neurochem Res; 1991 Oct; 16(10):1099-111. PubMed ID: 1686635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of GABA in the mediation and perception of pain.
    Enna SJ; McCarson KE
    Adv Pharmacol; 2006; 54():1-27. PubMed ID: 17175808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiepileptics from gamma-aminobutyric acid.
    Satzinger G
    Arzneimittelforschung; 1994 Mar; 44(3):261-6. PubMed ID: 8192689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schizophrenia as a neuronal illness.
    Freedman R
    Biol Psychiatry; 1999 Sep; 46(5):587-8. PubMed ID: 10472412
    [No Abstract]   [Full Text] [Related]  

  • 36. Clozapine and GABA transmission in schizophrenia disease models: establishing principles to guide treatments.
    O'Connor WT; O'Shea SD
    Pharmacol Ther; 2015 Jun; 150():47-80. PubMed ID: 25585121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia.
    Bristow GC; Bostrom JA; Haroutunian V; Sodhi MS
    Schizophr Res; 2015 Sep; 167(1-3):57-63. PubMed ID: 25660468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.
    Lewis DA; Hashimoto T; Morris HM
    Neurotox Res; 2008 Oct; 14(2-3):237-48. PubMed ID: 19073429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia.
    Lanctôt KL; Herrmann N; Mazzotta P; Khan LR; Ingber N
    Can J Psychiatry; 2004 Jul; 49(7):439-53. PubMed ID: 15362248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Gaba-ergic system and its importance for regulating respiration].
    Tarakanov IA; Safonov VA
    Fiziol Cheloveka; 1998; 24(5):116-28. PubMed ID: 9798328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.